Loading…
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions FY 2013 - Labor HHS Appropriations Bill
Client expense: $1,212,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions FY 2013 - Labor HHS Appropriations Bill
Client expense: $1,750,000 · Firm income: Not reported
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions FY 2013 - Labor HHS Appropriations Bill
Client expense: $1,440,000 · Firm income: Not reported
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions FY 2013 - Labor HHS Appropriations Bill
Client expense: $2,700,000 · Firm income: Not reported
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) R 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions
Client expense: $1,902,000 · Firm income: Not reported
| Democratic |
| ND |
| Carl Levin | Democratic | MI |
| Charles E. Schumer | Democratic | NY |
| Christopher Dodd | Democratic | CT |
| Daniel K. Inouye | Democratic | HI |
| Debbie Stabenow | Democratic | MI |
| Jon Tester | Democratic | MT |
| Kay R. Hagan | Democratic | NC |
| Kirsten E. Gillibrand | Democratic | NY |
| Robert P. Casey, Jr. | Democratic | PA |
| Roland Burris | Democratic | IL |
| Sheldon Whitehouse | Democratic | RI |
| Susan M. Collins | Republican | ME |
| Thad Cochran | Republican | MS |
| Tom Harkin | Democratic | IA |
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) R 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions
Client expense: $1,129,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) R 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions
Client expense: $1,631,812 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs Certified Importer Program (CIP) R 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions
Client expense: $1,918,136 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs R 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2011 - DOD Appropriations Bill 2011 Continuing Resolutions
Client expense: $1,650,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Health Issues
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs HR 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2010 Labor HHS Appropriations Bill - Pandemic Funding, Section 317 Program FY 2010 DoD Appropriations Bill - Transformational Medical Technologies Initiative Pandemic Funding
Client expense: $1,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Medicare/Medicaid
H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).
Client expense: $509,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2010 · fourth_quarter · Medicare/Medicaid
H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).
Client expense: $389,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2010 · fourth_quarter · Medicare/Medicaid
H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).
Client expense: $389,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs HR 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2010 Labor HHS Appropriations Bill - Pandemic Funding, Section 317 Program FY 2010 DoD Appropriations Bill - Transformational Medical Technologies Initiative Pandemic Funding
Client expense: $1,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Health Issues
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives. H.R. 6331, Generating Antibiotic Incentives Now Act of 2010. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565). The Health Care and Education Reconciliation Act of 2010 (HR 4872); the Patient Protection and Affordable Care Act (HR 3590); and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and Medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).
Client expense: $384,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2010 · fourth_quarter · Health Issues
H.R. 1458, S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009- immunosuppressive drug coverage provision S. 1796, America's Healthy Future act of 2009- Immunosuppressive drug coverage provision H.R. 3962, Affordable Health Care for America Act- Immunosuppressive drug coverage provision H.R. 3590, The Patient Protection and Affordable Care Act- immunosuppressive drug coverage provision HR 4872- Health Care and Education Reconciliation Act of 2010
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Medicare/Medicaid
H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; General issues pertaining to immunosupressives.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives. H.R. 6331, Generating Antibiotic Incentives Now Act of 2010. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R. 1458, S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009- immunosuppressive drug coverage provision S. 1796, America's Healthy Future act of 2009- Immunosuppressive drug coverage provision H.R. 3962, Affordable Health Care for America Act- Immunosuppressive drug coverage provision H.R. 3590, The Patient Protection and Affordable Care Act- immunosuppressive drug coverage provision HR 4872- Health Care and Education Reconciliation Act of 2010
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client expense: $80,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs HR 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2010 Labor HHS Appropriations Bill - Pandemic Funding, Section 317 Program FY 2010 DoD Appropriations Bill - Transformational Medical Technologies Initiative Pandemic Funding
Client expense: $1,842,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · third_quarter · Health Issues
S. 565, The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2010 · third_quarter · Government Issues
Public education related to organ donation and transplant issues. Federal appropriations, the Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2009 (H.R. 1458, S.565), the Living Donor Tax Credit Act of 2009 (H.R. 218) and the House and Senate FY11 Labor-HHS Appropriations bills.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.
Client expense: $795,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2010 · third_quarter · Medicare/Medicaid
The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565). The Health Care and Education Reconciliation Act of 2010 (HR 4872); the Patient Protection and Affordable Care Act (HR 3590); and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and Medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy Coverage Act of 2009 (HR 574/S 254)) The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. The Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590), and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).
Client expense: $310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Issues pertaining to antimicrobial resistance (the Strategies to Address Antimicrobial Resistance Act (HR 2400)). Issues pertaining to community and healthcare associated infections. Issues pertaining to medical isotopes (the American Medical Isotopes Production Act of 2009 (HR 3276)). Issues related to 340B program, follow on biologics, hospital readmissions/bundling and home infusion therapy coverage (the Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565), the Patient Protection and Affordable Care Act (HR 3590), Affordable Health Care for America Act (HR 3962), and the Health Care and Education Reconciliation Act of 2010 (HR 4872)). Issues related to oncology coverage (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)). Issues related to 340B (the American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)).
Client expense: $310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Medicare/Medicaid
Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy CoverageAct of 2009 (HR 574/S 254)) The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. The Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590), and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and medicare clinical trials, the 21st Century Cancer ALERT ("Access to Life-Saving Early detection, Research and Treatment" Act (HR1844)).
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
Issues pertaining to antimicrobial resistance (Strategies to Address Antimicrobial Resistance Act, (HR 2400)) Issues pertaining to community and healthcare associated infections Issues pertaining to medical isotopes (American Medical Isotopes Production Act of 2009 (HR 3276)) Issues related to the study of clinical effectiveness for immunosuppressant drugs Issues related to 340B program, follow on biologics, hospital readmissions/bundling and home infusion therapy coverage, the Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565), the Patient Protection and Affordable Care Act (HR 3590), Affordable Health Care for America Act (HR 3962), the Health Care and Education Reconciliation Act of 2010 (HR4872). Issues related to comparative clinical effectiveness of immunosuppressant drugs. Issues related to oncology coverage, the 21st Century Cancer ALERT ("Access to Life-Saving Early detection, Research and Treatment" Act (HR1844)). Issues related to comparative clinical effectiveness
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
Issues related to Medicare coverage of immunosuppressants; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S. 565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Health Care Act (H.R. 3950)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
Issues related to Medicare coverage of immunosuppressants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S. 565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Health Care Act (H.R.3950)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
H.R. 1458, S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009- immunosuppressive drug coverage provision S. 1796, America's Healthy Future act of 2009- Immunosuppressive drug coverage provision H.R. 3962, Affordable Health Care for America Act- Immunosuppressive drug coverage provision H.R. 3590, The Patient Protection and Affordable Care Act- immunosuppressive drug coverage provision HR 4872- Health Care and Education Reconciliation Act of 2010
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Medicare/Medicaid
H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
S. 565, The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
HR 1458 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 S565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 Pandemic Influenza Funding FDA Appropriations funding for Generic Drugs HR 7110 Job Creation and Unemployment Relief Act of 2008 HR 1 American Recovery and Reinvetment Act FY 2010 Labor HHS Appropriations Bill - Pandemic Funding, Section 317 Program FY 2010 DoD Appropriations Bill - Transformational Medical Technologies Initiative Pandemic Funding
Client expense: $1,616,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · second_quarter · Government Issues
Public education related to organ donation and transplant issues. Federal appropriations, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 (H.R. 1458, S. 565), the Living Donor Tax Credit Act of 2009 (H.R. 218) and the House and Senate FY11 Labor-HHS Appropriations bills.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Issues pertaining to antimicrobial resistance (the Strategies to Address Antimicrobial Resistance Act (HR 2400)). Issues pertaining to community and healthcare associated infections. Issues pertaining to medical isotopes (the American Medical Isotopes Production Act of 2009 (HR 3276)). Issues related to 340B program, follow on biologics, hospital readmissions/bundling and home infusion therapy coverage (the Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565), the Patient Protection and Affordable Care Act (HR 3590), Affordable Health Care for America Act (HR 3962), and the Health Care and Education Reconciliation Act of 2010 (HR 4872)). Issues related to oncology coverage (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)). Issues related to 340B (the American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213)).
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy Coverage Act of 2009 (HR 574/S 254)) The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. The Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590), and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
S. 565 and H.R. 1485, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills. S. 254 and H.R. 547, Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill.
Client expense: $980,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
2010 · second_quarter · Medicare/Medicaid
Issues related to Medicare coverage of immunosuppresants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 1458/S.565); American's Affordable Health Choices Act (H.R. 300); America's Healthy Future Act of 2009; Affordable Healthcare for America Act (H.R. 3862); Patient Protection and Affordable Care Act (H.R. 3590)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
Issues related to CPT codes for Myocardial Perfusion Imaging; H. R. 4371; H. R. 1458, and S. 565, Comprehensive Immunosuppressive Drug coverage for Transplant Patients Act; H. R. 574 & S. 254, Medicare Home Infusion Therapy Coverage Act of 2009.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
H.R. 1458/S. 565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act: Met with Ways and Means committee staff; advocacy to increase co-sponsorship of the bill
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE